Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 5:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2617–2640 of 145,407 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorder Clear all

Conditions: Maternal Sepsis, Infections
Interventions: Maternal Sepsis Safety Bundle; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: Female only
Enrollment: 33,183 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: New York, New York • The Bronx, New York

Conditions: Pancreatic Cancer
Interventions: Stereotactic Body Radiation Therapy; Radiation
Lead sponsor: University of Cincinnati; Other
Eligibility: 19 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Neuroendocrine Tumors, Carcinoma, Small Cell Lung, Neuroendocrine Carcinoma
Interventions: PEN-221; Drug
Lead sponsor: Tarveda Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 10
States / cities: Fort Myers, Florida • St. Petersburg, Florida • Boston, Massachusetts + 4 more

Conditions: Asthma
Interventions: High Efficiency Particulate Air Cleaner, Sham air cleaner; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Autism Spectrum Disorders
Interventions: Sensory Supported Swimming; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 4 Years to 18 Years
Enrollment: 353 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2026
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Type 2 Diabetes Mellitus
Interventions: S-707106 Dose A, S-707106 Dose B, S-707106 Dose C, Placebo A tablet, Metformin; Drug
Lead sponsor: Shionogi; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cancer
Interventions: Psilocybin, Niacin; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 76 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Congestive Heart Failure, Metastatic Cancer, Chronic Kidney Disease Requiring Chronic Dialysis, Chronic Obstructive Pulmonary Disease
Interventions: ED GOAL; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Colorectal Neoplasms
Interventions: Underwater resection, Conventional (gas distended colon) resection, Standard polypectomy; Procedure
Lead sponsor: VA Northern California Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Mather, California

Conditions: Recurrent Acute Myeloid Leukemia
Interventions: Venetoclax, Decitabine, Cedazuridine, Bone Marrow Aspiration and Biopsy, Biospecimen Collection; Drug · Procedure
Lead sponsor: Sanjay Mohan; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sleep Insufficiency, Sleep, Adolescent Behavior
Interventions: Light, CBT, Sham Light; Device · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 14 Years to 18 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Prostate Cancer
Interventions: hydroxychloroquine; Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older · Male only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2018
U.S. locations: 5
States / cities: Hamilton, New Jersey • Morristown, New Jersey • New Brunswick, New Jersey + 2 more

Conditions: Glaucoma, Open-Angle
Interventions: Standard Automatic Perimetry Humphrey Field Analyzer, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT); Diagnostic Test
Lead sponsor: Wills Eye; Other
Eligibility: 20 Years to 80 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Male Infertility
Interventions: YoSperm; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Psoriatic Arthritis
Interventions: 210 mg brodalumab, 140 mg brodalumab, Placebo; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 31
States / cities: Peoria, Arizona • Little Rock, Arkansas • Cypress, California + 26 more

Conditions: Multiple Myeloma
Interventions: Pomalidomide, stem cell, Dexamethasone, Clarithromycin; Drug · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2025
U.S. locations: 10
States / cities: Basking Ridge, New Jersey • New Brunswick, New Jersey • Commack, New York + 6 more

Conditions: Short Bowel Syndrome, Malabsorption, Malnutrition
Interventions: HPN Group Clinic Appointments using Mobile Devices (experimental), Mobile Device Access (placebo); Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 13 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Influenza, Human
Interventions: mRNA Seasonal Flu vaccine, Comparator 1, Comparator 2; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 12
States / cities: Glendale, Arizona • Tucson, Arizona • San Diego, California + 9 more

Conditions: Lymphoma, Non-Hodgkin, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic
Interventions: SGN-35; Drug
Lead sponsor: Seagen Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 4
States / cities: Birmingham, Alabama • St Louis, Missouri • New York, New York + 1 more

Conditions: Spinal Cord Injuries
Interventions: Motor-assisted arms and legs cycling; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 75 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: Dietary Intervention, Dietary Control; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older · Female only
Enrollment: 153 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Osteogenesis Imperfecta, Brittle Bone Disorders
Interventions: Web-based Survey; Other
Lead sponsor: University of South Florida; Other
Eligibility: Female only
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Chronic Obstructive Lung Disease
Interventions: Not listed
Lead sponsor: Philip Diaz; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Type 2 Diabetes Mellitus, Obesity
Interventions: Not listed
Lead sponsor: University of Arizona; Other
Eligibility: 21 Years to 65 Years
Enrollment: 72 participants
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tucson, Arizona

Search by objective public record fields.

EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)

Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body

PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers

Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response

Sensory Supported Swimming for Children With ASD

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Psilocybin Cancer Anxiety Study

Advance Care Planning in the Emergency Department

Underwater Resection of Non-pedunculated Colorectal Lesions

Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant

Shifting Sleep Timing in Teens

Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Evaluating Home Testing Devices for the Management of Glaucoma

Home Semen Testing in Men Beginning Attempts to Conceive

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research

A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

Arm and Leg Cycling for Accelerated Recovery From SCI

Rx for Better Breast Health

Pregnancy in Osteogenesis Imperfecta (OI) Registry

A Registry of COPD Patients to be Used for Future Studies

MOLECULAR REGULATION OF MUSCLE GLUCOSE METABOLISM (AIMS 2A, 2B, 3)